Fingerprint
Dive into the research topics of 'Antiviral effects and safety of telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in hepatitis C patients'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Antiviral effects and safety of telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in hepatitis C patients
Eric Lawitz, Maribel Rodriguez-Torres, Andrew J. Muir, Tara L. Kieffer, Lindsay McNair, Ariya Khunvichai, John G. McHutchison
Research output: Contribution to journal › Article › peer-review
122
Scopus
citations